AU2001283462A1 - Treatment of helicobacter with isothiocyanates - Google Patents

Treatment of helicobacter with isothiocyanates

Info

Publication number
AU2001283462A1
AU2001283462A1 AU2001283462A AU8346201A AU2001283462A1 AU 2001283462 A1 AU2001283462 A1 AU 2001283462A1 AU 2001283462 A AU2001283462 A AU 2001283462A AU 8346201 A AU8346201 A AU 8346201A AU 2001283462 A1 AU2001283462 A1 AU 2001283462A1
Authority
AU
Australia
Prior art keywords
isothiocyanates
helicobacter
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001283462A
Inventor
Jed W. Fahey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22849247&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2001283462(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of AU2001283462A1 publication Critical patent/AU2001283462A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/26—Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
AU2001283462A 2000-08-21 2001-08-21 Treatment of helicobacter with isothiocyanates Abandoned AU2001283462A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22652000P 2000-08-21 2000-08-21
US60/226,520 2000-08-21
PCT/US2001/025993 WO2002015722A2 (en) 2000-08-21 2001-08-21 Treatment of helicobacter with isothiocyanates

Publications (1)

Publication Number Publication Date
AU2001283462A1 true AU2001283462A1 (en) 2002-03-04

Family

ID=22849247

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001283462A Abandoned AU2001283462A1 (en) 2000-08-21 2001-08-21 Treatment of helicobacter with isothiocyanates

Country Status (7)

Country Link
US (2) US6737441B2 (en)
EP (1) EP1313377B1 (en)
JP (2) JP5132865B2 (en)
KR (1) KR100880498B1 (en)
CN (1) CN100522154C (en)
AU (1) AU2001283462A1 (en)
WO (1) WO2002015722A2 (en)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100522154C (en) * 2000-08-21 2009-08-05 杰德W·费伊 Use of isothiocyanates compound for treatment of helicobacter
US7407986B2 (en) 2001-12-18 2008-08-05 Brassica Foundation For Chemoprotection Research, Inc. Prevention and treatment of oxidative stress disorders by glutathione and phase II detoxification enzymes
WO2004037244A1 (en) * 2002-09-25 2004-05-06 Andrea Marinello Apparatus for the treatment of maxillary and frontal sinusitis and neuritis and neuralgia of the trigeminal nerve
CA2520902C (en) * 2003-03-31 2011-01-25 Council Of Scientific And Industrial Research Novel nitrile glycoside useful as a bio-enhancer of drugs and nutrients, process of its isolation from moringa oleifera.
US6858588B2 (en) * 2003-03-31 2005-02-22 Council Of Scientific And Industrial Research Nitrile glycoside useful as a bioenhancer of drugs and nutrients, process of its isolation from moringa oleifera
US20110061679A1 (en) * 2004-06-17 2011-03-17 Uvtech Systems, Inc. Photoreactive Removal of Ion Implanted Resist
JPWO2006030907A1 (en) * 2004-09-16 2008-05-15 レドックス・バイオサイエンス株式会社 Retinal protective agent
JP2006151861A (en) * 2004-11-29 2006-06-15 Redox Bioscience Inc Preventing and treating agent of organ disorder caused by smoking
US20060127996A1 (en) * 2004-12-14 2006-06-15 Johns Hopkins University Method of extraction of isothiocyanates into oil from glucosinolate-containing plants and method of producing products with oil containing isothiocyanates extracted from glucosinolate-containing plants
US7744937B2 (en) 2005-08-09 2010-06-29 Kraft Foods Global Brands Llc Chemoprotectants from crucifer seeds and sprouts
US7404975B2 (en) * 2006-05-10 2008-07-29 Academia Sinica Moringa crude extracts and their derived fractions with antifungal activities
US8859798B2 (en) 2006-07-06 2014-10-14 Rutgers, The State University Of New Jersey Isothiocyanate compounds, pharmaceutical compositions, and uses thereof
KR100855097B1 (en) * 2006-12-18 2008-08-29 이정상 Composition for anti-helicobacter pylori comprising n-acetyl-n-cysteine
EP2796140B1 (en) * 2007-01-23 2018-05-02 Pharmagra Labs, Inc. Stabilized Sulforaphane
US20080306148A1 (en) 2007-04-13 2008-12-11 The Penn State Research Foundation Anti-cancer compositions and methods
JP4568302B2 (en) * 2007-05-18 2010-10-27 株式会社日立製作所 Vehicle longitudinal acceleration control apparatus using jerk information
US20080311192A1 (en) * 2007-06-12 2008-12-18 Kraft Foods Holdings, Inc. Enteric-Coated Glucosinolates And Beta-Thioglucosidases
US20080311276A1 (en) * 2007-06-12 2008-12-18 Kraft Foods Holdings, Inc. Production of Glucosinolates from Agricultural By-Products & Waste
DK2080516T3 (en) * 2008-01-18 2011-07-11 Indena Spa Use of isothiocyanate derivatives as anti-myeloma agents
US8003633B1 (en) 2008-04-14 2011-08-23 The Penn State Research Foundation Anti-cancer compositions and methods
KR101028865B1 (en) * 2008-06-30 2011-04-12 중앙대학교 산학협력단 A method of separation to sulforaphene from Raphanus sativus L and the use of sulforaphene
KR101028864B1 (en) * 2008-06-30 2011-04-12 중앙대학교 산학협력단 A method of separation to sulforaphene from Baemuchae and the use of sulforaphene
JP5824194B2 (en) * 2009-02-12 2015-11-25 金印株式会社 Testosterone enhancer for addition to food and drink or animal feed
EP2229824A1 (en) 2009-03-12 2010-09-22 Nestec S.A. Covalent milk protein/isothiocyanate complexes
KR101171871B1 (en) 2009-05-13 2012-08-07 중앙대학교 산학협력단 Antibacterial composition comprising Sulforaphene as an effective ingredient
CN102905713A (en) 2010-03-11 2013-01-30 健康研究股份有限公司 A novel method for delivery and use of isothiocyanates for prophylaxis and/or therapy of bladder cancer
BE1019434A3 (en) 2010-07-23 2012-07-03 Auriga Internat STABILIZATION OF SULFORAPHANE.
JP2012060995A (en) * 2010-08-18 2012-03-29 Utsunomiya Univ Method for producing japanese radish powder, method for antibacterializing, disinfecting and storing food, and food antibacterialized and disinfected to helicobacter pylori
US10647668B2 (en) 2011-01-03 2020-05-12 The William M. Yarbrough Foundation Isothiocyanate functional surfactant and associated method of use
US11407713B2 (en) 2011-01-03 2022-08-09 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US11279674B2 (en) 2011-01-03 2022-03-22 The William M. Yarbrough Foundation Isothiocyanate functional surfactant and associated method of use
US10308599B2 (en) 2011-01-03 2019-06-04 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US10640464B2 (en) 2011-01-03 2020-05-05 The William M. Yarbrough Foundation Use of isothiocyanate functional surfactants as Nrf2 inducers to treat epidermolysis bullosa simplex and related diseases
US10273205B2 (en) 2011-01-03 2019-04-30 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms
US8933119B2 (en) 2011-01-03 2015-01-13 The William M. Yarbrough Foundation Method for treating phytophotodermatitis
US9962361B2 (en) 2011-01-03 2018-05-08 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US8865765B2 (en) 2011-01-12 2014-10-21 The William M. Yarbrough Foundation Method for treating eczema
US9532969B2 (en) 2011-02-08 2017-01-03 The William M. Yarbrough Foundation Method for treating psoriasis
CN103458921B (en) 2011-02-22 2016-05-11 考迪尔种子公司 Spray-dired myrosin and for the production of the purposes of isothiocyanates
US20140050687A1 (en) 2011-04-28 2014-02-20 Estman Chemical Company Betaine esters and process for making and using
FR2977161B1 (en) * 2011-07-01 2013-07-19 Sojasun Technologies COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF PROSTATE CANCER BASED ON BROCOLI SEED EXTRACT.
CA2875063C (en) 2012-06-01 2021-01-12 Pharmagra Labs, Inc. Method of synthesising sulforaphane
US20150174213A1 (en) * 2012-07-05 2015-06-25 Nutramax Laboratories, Inc. Compositions comprising sulforaphane or a sulforaphane precursor and ursolic acid
US9839621B2 (en) 2012-07-26 2017-12-12 The William M. Yarbrough Foundation Method for treating bladder cancer
US9949943B2 (en) 2012-07-26 2018-04-24 The William M. Yarbrough Foundation Method for treating neurodegenerative diseases
US10434081B2 (en) 2012-07-26 2019-10-08 The William M. Yarbrough Foundation Inhibitors of macrophage migration inhibitory factor
US10434082B2 (en) 2012-07-26 2019-10-08 The William M. Yarbrough Foundation Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms
US10080734B2 (en) 2012-07-26 2018-09-25 The William M. Yarbrough Foundation Method for treating autism and other neurodevelopmental disorders
US10441561B2 (en) 2012-07-26 2019-10-15 The William M. Yanbrough Foundation Method for treating benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer
WO2014018874A1 (en) 2012-07-26 2014-01-30 The William M. Yarbrough Foundation Method for treating skin cancer
US10335387B2 (en) 2012-07-26 2019-07-02 The William M. Yarbrough Foundation Method for treating infectious diseases with isothiocyanate functional compounds
CN104710337B (en) * 2015-02-12 2016-11-23 领思科技(大连)有限公司 Isosulfocyanate compound and application thereof
KR101756775B1 (en) * 2015-10-15 2017-07-26 남부대학교산학협력단 Compositions for treating, improving or preventing for diseases derived from helicobacter pylori
DE202016106397U1 (en) 2015-11-30 2017-03-08 Richard Gorniak Agent for preferably cancer-preventive treatment in humans
RU2646450C1 (en) * 2017-05-11 2018-03-05 Владимир Михайлович Курусин Method of treatment of precancerous and early stages of cancerous diseases of gaster
WO2020060264A1 (en) * 2018-09-20 2020-03-26 동국대학교 경주캠퍼스 산학협력단 Composition comprising sulforaphane derivative for prevention, treatment, or alleviation of muscle atrophy and sarcopenia
CN109480231A (en) * 2018-11-16 2019-03-19 广州普维君健药业有限公司 The composition of anti-helicobacter pylori and its application
CN111983099A (en) * 2020-09-01 2020-11-24 山东省农业科学院农业质量标准与检测技术研究所 Method for measuring sulforaphane and sulforaphane in cruciferous vegetables by using HPLC (high performance liquid chromatography) method

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61143353A (en) 1984-05-11 1986-07-01 Denki Kagaku Kogyo Kk Production of thiocyanate and/or isothiocyanate
US5114969A (en) * 1989-03-22 1992-05-19 American Health Foundation Method of inhibiting lung tumors, arylalkyl isothiocyanates, and method of synthesizing same
NZ236018A (en) * 1989-11-09 1993-03-26 Minato Co Ltd Sterilisation of air, water and perishable foodstuffs using isothiocyanic acid ester vapour, compositions and apparatus for generating such
GB9214419D0 (en) * 1992-07-07 1992-08-19 Concannon Peter Biocidal agents
US5411986A (en) 1993-03-12 1995-05-02 The Johns Hopkins University Chemoprotective isothiocyanates
US5589504A (en) * 1994-07-26 1996-12-31 Cornell Research Foundation, Inc. Treatment of newborn jaundice
US5725895B1 (en) * 1995-09-15 2000-10-10 Hopkins J School Of Medicine Method of preparing food product from cruciferous seeds
US5686108A (en) * 1995-09-27 1997-11-11 Amway Corporation Brassica vegetable supplement and process for manufacture
SE506529C2 (en) * 1996-01-23 1997-12-22 Semper Ab Use of a lactoperoxidase system for the preparation of a drug against Helicobacter pylori
JPH1075751A (en) * 1996-08-30 1998-03-24 Genyo Midorikawa Health beverage containing wasabia japonica or western mustard
FR2778312B1 (en) * 1998-04-09 2004-04-02 Plant Bioscience Ltd PROCESS FOR THE SELECTIVE INCREASE OF ANTICARCINOGENIC GLUCOSINOLATES
US6348220B1 (en) * 1999-04-09 2002-02-19 Rutgers, The State University Of New Jersey Phenethylisothiocyanate nutraceutical compositions and methods
JP3567174B2 (en) * 1999-12-13 2004-09-22 独立行政法人産業技術総合研究所 Novel leukemia cell growth inhibitor
CN100522154C (en) * 2000-08-21 2009-08-05 杰德W·费伊 Use of isothiocyanates compound for treatment of helicobacter

Also Published As

Publication number Publication date
JP2004519423A (en) 2004-07-02
JP2013006849A (en) 2013-01-10
US6737441B2 (en) 2004-05-18
WO2002015722A2 (en) 2002-02-28
US20040180843A1 (en) 2004-09-16
EP1313377B1 (en) 2015-01-21
CN1469711A (en) 2004-01-21
KR20030055251A (en) 2003-07-02
US20020151505A1 (en) 2002-10-17
JP5132865B2 (en) 2013-01-30
CN100522154C (en) 2009-08-05
KR100880498B1 (en) 2009-01-28
US7402569B2 (en) 2008-07-22
WO2002015722A3 (en) 2002-08-08
EP1313377A2 (en) 2003-05-28

Similar Documents

Publication Publication Date Title
AU2001283462A1 (en) Treatment of helicobacter with isothiocyanates
AU2001267079A1 (en) Integrated electronic-optoelectronic devices and method of making the same
AU2002223827A1 (en) Well treatment
AU2001260513A1 (en) Microcapsule well treatment
AU3867400A (en) Methods of using bioelastomers
AU2002213435A1 (en) Seed treatment with combinations of insecticides
AU2001280599A1 (en) Compounds and methods
AU2001253418A1 (en) Compounds and methods
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
EP1183030A4 (en) Methods of making and using n-desmethylzopiclone
AU2001286983A1 (en) Method of treatment
AU1772399A (en) Well treatment
AU2002211183A1 (en) Prosthetic construct and methods for its manufacture and use
AU2001243394A1 (en) Compounds and methods
AU2002231206A1 (en) Treatment of depression
AU5866800A (en) Soft diving stick
AU2001260834A1 (en) The treatment of herpes
AU3960801A (en) Gear and procedure of achievement
AU2001232263A1 (en) Method of treating seeds
AUPQ872300A0 (en) Compounds and methods
AU2002210916A1 (en) Endoscope attachment and endoscope
AU2002227925A1 (en) Human beta-defensin-3
AU2001236929A1 (en) Surface treatment
AU5622501A (en) Floating body
AU2001278951A1 (en) Compounds and methods